ACTIVE HALF-LIFE
A few minutes
CLASSIFICATION
?-Melanocyte-Stimulating Hormone Analogue
DOSAGE
5 mg/day
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Beligas
WAREHOUSE
International Warehouse 3
SUBSTANCE
Melanocyte-stimulating hormone (MSH)
Introducing Melanotan 1, a cutting-edge synthetic analogue of the melanocyte-stimulating hormone (?-MSH). This innovative peptide is designed to enhance skin pigmentation by stimulating melanogenesis?the natural process of melanin production. Melanin is your skin's natural shield against harmful UV rays, effectively absorbing, reflecting, and refracting light to protect cellular integrity. With Melanotan, achieve deeper, darker melanin production that significantly reduces sun damage for your skin.
Melanotan Dosage:
The recommended dosage for optimal results ranges from 250 mcg to 2 mg daily.
Melanotan Results:
Experience a remarkable increase in eumelanin (the darker pigment), enhancing your tanning potential beyond normal physiological limits. Administering Melanotan 1 promotes a more robust and effective tanning process.
Research Use:
Melanotan peptides are known for their short half-life. Currently, afamelanotide is being developed as an innovative implant for dermatological use, offering a controlled release of the peptide to improve melanin density over several months. Melanotan 1 is accessible online in research peptide form for convenient low-dose subcutaneous injections.
Lifestyle:
Melanotan represents a potential breakthrough in cosmetic treatment, akin to Botox or Viagra. It can be utilized continuously or intermittently to suit your needs.
Recommended Therapy:
For effective results, an intermittent therapy regimen is advised, lasting from 10 days for skin type III to up to 6 months for skin type I. It's crucial to monitor the duration of elevated melanin density after Melanotan administration.
Peptide Molecule:
In developing Melanotan 1, two amino acids in the body?s natural ?-MSH are modified to enhance stability. This peptide is intended for subcutaneous injection only.
Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2
Amino Acid Sequence:
Clinical Trial:
Melanotan remains in the clinical trial stage and has not received official approval. Users engage with it for research purposes only. Mild side effects, such as transient nausea and flushing, may occur post-injection but are usually brief.
Administration of Research Melanotan:
For safe and regulated use in research, afamelanotide administration mimics that of Melanotan 2. Melanotan 1 is available in multi-dose sterile vials. Alternative forms like implants, nasal sprays, or pills are not currently effective.
While Melanotan 1 may require a dosage 8-10 times higher than Melanotan 2 for similar tanning results, it is favored by users seeking minimal side effects with a focus on photoprotection. Patience and careful preparation are key throughout your Melanotan journey.
Melanotan therapy provides a pathway to develop a protective tan, mimicking the natural tanning response to UV-induced cellular damage. Ultraviolet rays penetrate the skin, activating ?-MSH and stimulating melanin production. This melanin acts as a natural barrier against sun damage, and Melanotan injections may offer a safer alternative for achieving a cosmetic tan with reduced skin harm.
Please remember that the information on this website is not a substitute for professional medical advice and is not intended for the diagnosis, treatment, cure, or prevention of any disease.